Go Pro

Templeton Emerging Markets Fund (EMF) Competitors

Templeton Emerging Markets Fund logo
$21.94 -0.21 (-0.95%)
Closing price 03:58 PM Eastern
Extended Trading
$21.94 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EMF vs. HQH, ORC, MSDL, OPY, and DFIN

Should you buy Templeton Emerging Markets Fund stock or one of its competitors? MarketBeat compares Templeton Emerging Markets Fund with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Templeton Emerging Markets Fund include abrdn Healthcare Investors (HQH), Orchid Island Capital (ORC), Morgan Stanley Direct Lending Fund (MSDL), Oppenheimer (OPY), and Donnelley Financial Solutions (DFIN). These companies are all part of the "capital markets" industry.

How does Templeton Emerging Markets Fund compare to abrdn Healthcare Investors?

Templeton Emerging Markets Fund (NYSE:EMF) and abrdn Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Templeton Emerging Markets Fund pays an annual dividend of $0.90 per share and has a dividend yield of 4.1%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 10.3%.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Templeton Emerging Markets Fund$141.07M2.32N/AN/AN/A
abrdn Healthcare Investors$253.93M5.09N/AN/AN/A

49.9% of Templeton Emerging Markets Fund shares are owned by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, abrdn Healthcare Investors had 2 more articles in the media than Templeton Emerging Markets Fund. MarketBeat recorded 2 mentions for abrdn Healthcare Investors and 0 mentions for Templeton Emerging Markets Fund. abrdn Healthcare Investors' average media sentiment score of 0.65 beat Templeton Emerging Markets Fund's score of 0.59 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media.

Company Overall Sentiment
Templeton Emerging Markets Fund Positive
abrdn Healthcare Investors Positive

Company Net Margins Return on Equity Return on Assets
Templeton Emerging Markets FundN/A N/A N/A
abrdn Healthcare Investors N/A N/A N/A

Templeton Emerging Markets Fund has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Summary

abrdn Healthcare Investors beats Templeton Emerging Markets Fund on 6 of the 8 factors compared between the two stocks.

How does Templeton Emerging Markets Fund compare to Orchid Island Capital?

Orchid Island Capital (NYSE:ORC) and Templeton Emerging Markets Fund (NYSE:EMF) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Orchid Island Capital's return on equity of 11.87% beat Templeton Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Orchid Island CapitalN/A 11.87% 1.35%
Templeton Emerging Markets Fund N/A N/A N/A

Orchid Island Capital pays an annual dividend of $1.20 per share and has a dividend yield of 18.6%. Templeton Emerging Markets Fund pays an annual dividend of $0.90 per share and has a dividend yield of 4.1%. Orchid Island Capital pays out 81.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Orchid Island Capital has increased its dividend for 1 consecutive years. Orchid Island Capital is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Orchid Island Capital has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market. Comparatively, Templeton Emerging Markets Fund has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market.

Orchid Island Capital currently has a consensus price target of $7.50, suggesting a potential upside of 16.55%. Given Orchid Island Capital's stronger consensus rating and higher probable upside, research analysts plainly believe Orchid Island Capital is more favorable than Templeton Emerging Markets Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orchid Island Capital
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Templeton Emerging Markets Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Orchid Island Capital has higher revenue and earnings than Templeton Emerging Markets Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orchid Island Capital$270.14M4.75$159.03M$1.484.35
Templeton Emerging Markets Fund$141.07M2.32N/AN/AN/A

In the previous week, Orchid Island Capital had 4 more articles in the media than Templeton Emerging Markets Fund. MarketBeat recorded 4 mentions for Orchid Island Capital and 0 mentions for Templeton Emerging Markets Fund. Templeton Emerging Markets Fund's average media sentiment score of 0.59 beat Orchid Island Capital's score of 0.02 indicating that Templeton Emerging Markets Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Orchid Island Capital Neutral
Templeton Emerging Markets Fund Positive

32.7% of Orchid Island Capital shares are owned by institutional investors. Comparatively, 49.9% of Templeton Emerging Markets Fund shares are owned by institutional investors. 0.3% of Orchid Island Capital shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Orchid Island Capital beats Templeton Emerging Markets Fund on 11 of the 14 factors compared between the two stocks.

How does Templeton Emerging Markets Fund compare to Morgan Stanley Direct Lending Fund?

Morgan Stanley Direct Lending Fund (NYSE:MSDL) and Templeton Emerging Markets Fund (NYSE:EMF) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Morgan Stanley Direct Lending Fund has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, Templeton Emerging Markets Fund has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

Morgan Stanley Direct Lending Fund has higher revenue and earnings than Templeton Emerging Markets Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Direct Lending Fund$397.29M3.22$122.09M$1.0114.94
Templeton Emerging Markets Fund$141.07M2.32N/AN/AN/A

In the previous week, Morgan Stanley Direct Lending Fund had 2 more articles in the media than Templeton Emerging Markets Fund. MarketBeat recorded 2 mentions for Morgan Stanley Direct Lending Fund and 0 mentions for Templeton Emerging Markets Fund. Templeton Emerging Markets Fund's average media sentiment score of 0.59 beat Morgan Stanley Direct Lending Fund's score of -0.50 indicating that Templeton Emerging Markets Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Morgan Stanley Direct Lending Fund Negative
Templeton Emerging Markets Fund Positive

49.9% of Templeton Emerging Markets Fund shares are held by institutional investors. 0.3% of Morgan Stanley Direct Lending Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Morgan Stanley Direct Lending Fund has a net margin of 22.84% compared to Templeton Emerging Markets Fund's net margin of 0.00%. Morgan Stanley Direct Lending Fund's return on equity of 9.73% beat Templeton Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Direct Lending Fund22.84% 9.73% 4.37%
Templeton Emerging Markets Fund N/A N/A N/A

Morgan Stanley Direct Lending Fund pays an annual dividend of $1.80 per share and has a dividend yield of 11.9%. Templeton Emerging Markets Fund pays an annual dividend of $0.90 per share and has a dividend yield of 4.1%. Morgan Stanley Direct Lending Fund pays out 178.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Morgan Stanley Direct Lending Fund currently has a consensus target price of $15.63, suggesting a potential upside of 3.55%. Given Morgan Stanley Direct Lending Fund's stronger consensus rating and higher possible upside, analysts plainly believe Morgan Stanley Direct Lending Fund is more favorable than Templeton Emerging Markets Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Morgan Stanley Direct Lending Fund
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
Templeton Emerging Markets Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Morgan Stanley Direct Lending Fund beats Templeton Emerging Markets Fund on 11 of the 15 factors compared between the two stocks.

How does Templeton Emerging Markets Fund compare to Oppenheimer?

Oppenheimer (NYSE:OPY) and Templeton Emerging Markets Fund (NYSE:EMF) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

Oppenheimer has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Templeton Emerging Markets Fund has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

Oppenheimer pays an annual dividend of $0.80 per share and has a dividend yield of 0.7%. Templeton Emerging Markets Fund pays an annual dividend of $0.90 per share and has a dividend yield of 4.1%. Oppenheimer pays out 9.0% of its earnings in the form of a dividend. Oppenheimer has raised its dividend for 1 consecutive years.

Oppenheimer has a net margin of 5.72% compared to Templeton Emerging Markets Fund's net margin of 0.00%. Oppenheimer's return on equity of 19.51% beat Templeton Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Oppenheimer5.72% 19.51% 4.86%
Templeton Emerging Markets Fund N/A N/A N/A

Oppenheimer has higher revenue and earnings than Templeton Emerging Markets Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oppenheimer$1.64B0.76$148.40M$8.8613.07
Templeton Emerging Markets Fund$141.07M2.32N/AN/AN/A

32.3% of Oppenheimer shares are owned by institutional investors. Comparatively, 49.9% of Templeton Emerging Markets Fund shares are owned by institutional investors. 34.9% of Oppenheimer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oppenheimer
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Templeton Emerging Markets Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Oppenheimer had 10 more articles in the media than Templeton Emerging Markets Fund. MarketBeat recorded 10 mentions for Oppenheimer and 0 mentions for Templeton Emerging Markets Fund. Oppenheimer's average media sentiment score of 0.84 beat Templeton Emerging Markets Fund's score of 0.59 indicating that Oppenheimer is being referred to more favorably in the media.

Company Overall Sentiment
Oppenheimer Positive
Templeton Emerging Markets Fund Positive

Summary

Oppenheimer beats Templeton Emerging Markets Fund on 11 of the 15 factors compared between the two stocks.

How does Templeton Emerging Markets Fund compare to Donnelley Financial Solutions?

Donnelley Financial Solutions (NYSE:DFIN) and Templeton Emerging Markets Fund (NYSE:EMF) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Donnelley Financial Solutions has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market. Comparatively, Templeton Emerging Markets Fund has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

Donnelley Financial Solutions currently has a consensus target price of $61.00, indicating a potential upside of 22.98%. Given Donnelley Financial Solutions' stronger consensus rating and higher probable upside, equities research analysts clearly believe Donnelley Financial Solutions is more favorable than Templeton Emerging Markets Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Donnelley Financial Solutions
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.80
Templeton Emerging Markets Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Donnelley Financial Solutions had 17 more articles in the media than Templeton Emerging Markets Fund. MarketBeat recorded 17 mentions for Donnelley Financial Solutions and 0 mentions for Templeton Emerging Markets Fund. Donnelley Financial Solutions' average media sentiment score of 0.62 beat Templeton Emerging Markets Fund's score of 0.59 indicating that Donnelley Financial Solutions is being referred to more favorably in the media.

Company Overall Sentiment
Donnelley Financial Solutions Positive
Templeton Emerging Markets Fund Positive

Donnelley Financial Solutions has higher revenue and earnings than Templeton Emerging Markets Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Donnelley Financial Solutions$767M1.59$32.40M$1.4534.21
Templeton Emerging Markets Fund$141.07M2.32N/AN/AN/A

93.8% of Donnelley Financial Solutions shares are owned by institutional investors. Comparatively, 49.9% of Templeton Emerging Markets Fund shares are owned by institutional investors. 5.2% of Donnelley Financial Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Donnelley Financial Solutions has a net margin of 4.53% compared to Templeton Emerging Markets Fund's net margin of 0.00%. Donnelley Financial Solutions' return on equity of 25.82% beat Templeton Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Donnelley Financial Solutions4.53% 25.82% 12.29%
Templeton Emerging Markets Fund N/A N/A N/A

Summary

Donnelley Financial Solutions beats Templeton Emerging Markets Fund on 12 of the 14 factors compared between the two stocks.

Get Templeton Emerging Markets Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for EMF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EMF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EMF vs. The Competition

MetricTempleton Emerging Markets FundCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$327.96M$5.62B$14.06B$24.10B
Dividend Yield4.25%7.47%5.92%3.71%
P/E RatioN/A38.0529.3431.87
Price / Sales2.321,200.19504.7820.26
Price / CashN/A48.2238.6131.79
Price / BookN/A3.713.736.93
Net IncomeN/A$417.17M$1.31B$1.07B
7 Day Performance9.28%1.70%1.49%2.63%
1 Month Performance-1.77%-0.11%1.31%1.55%
1 Year Performance47.20%7.18%13.62%19.52%

Templeton Emerging Markets Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EMF
Templeton Emerging Markets Fund
N/A$21.94
-0.9%
N/A+48.8%$327.96M$141.07MN/AN/A
HQH
abrdn Healthcare Investors
N/A$22.59
+1.1%
N/A+41.3%$1.29BN/AN/A147,000
ORC
Orchid Island Capital
3.399 of 5 stars
$6.43
+0.7%
$7.50
+16.7%
-10.8%$1.28B$270.14M4.342,018
MSDL
Morgan Stanley Direct Lending Fund
1.8824 of 5 stars
$15.07
-0.9%
$15.63
+3.7%
-18.0%$1.28B$397.29M14.92N/A
OPY
Oppenheimer
1.8961 of 5 stars
$116.11
-0.7%
N/A+58.0%$1.24B$1.64B13.102,947

Related Companies and Tools


This page (NYSE:EMF) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners